Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Research Biosimilar

Research Grade Varokibart

Catalog #:   DHC13604 Specific References (50) DATASHEET
Host species: Human
Isotype: IgG4-kappa
Applications: Research Grade Biosimilar
Expression system: Mammalian Cells
Overview

Catalog No.

DHC13604

Expression system

Mammalian Cells

Species reactivity

Human

Host species

Human

Isotype

IgG4-kappa

Clonality

Monoclonal

Target

IL5, B-cell differentiation factor I, IL-5, T-cell replacing factor, TRF, Eosinophil differentiation factor, Interleukin-5

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

P05113

Applications

Research Grade Biosimilar

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Alternative Names

CAS: 2643349-04-4

Clone ID

Varokibart

Data Image
References

Multifunctional Nanoplatform for Highly Accurate Profiling of Triple-Negative Breast Cancer-Derived Chemo- and Immunotherapy Resistance Exosomes., PMID:40526975

Wolf isotopic response: immunotherapy-related lichenoid eruption localizing to prior radiation site., PMID:40526967

Drug-induced subacute cutaneous lupus erythematous from cenobamate: case presentation and review of the literature., PMID:40526960

Enfortumab vedotin-induced widespread vesiculobullous eruption mimicking disseminated herpetic infection in a patient with metastatic urothelial carcinoma., PMID:40526955

Rituximab treatment of refractory skin involvement in anti-TIF1 gamma dermatomyositis., PMID:40526941

Characterization of a Single-Molecule Sensitive Digital Flow Cytometer for Amplification-Free Digital Assays., PMID:40526870

IGSF9-targeted therapy inhibits the progression of acute myeloid leukemia., PMID:40526840

Collaboration and Decision-Support Tools to Mitigate Nirmatrelvir/Ritonavir Drug Interactions., PMID:40526767

Prevalence of dengue in febrile patients in Peru: A systematic review and meta-analysis., PMID:40526741

Treatment Options for the Comorbidity of Multiple Sclerosis With Other Chronic Inflammatory Diseases., PMID:40526577

An endothelial cell competition assay for determinants of the response to targeted anti-angiogenics., PMID:40526406

Erenumab for Chronic Cluster Headache: A Randomized Clinical Trial., PMID:40526384

Two-Dimensional TiO2 Ultraviolet Filters for Sunscreens., PMID:40526263

Tislelizumab and GP regimen neoadjuvant therapy followed by concurrent chemoradiotherapy with nimotuzumab in patients with stage IVA nasopharyngeal carcinoma: a retrospective study., PMID:40526208

Preclinical Evaluation of a Near-Infrared Labelled Antibody Targeting the Tumour Associated Xenoantigen N-Glycolyl-Neuraminic Acid GM3 Ganglioside., PMID:40526182

SUMO2 inhibits ACSL3 protein degradation to antagonize erastin-induced ferroptosis in hepatocellular carcinoma., PMID:40526170

ORM1 Mediates Ln-IgG-Induced Podocyte Damage and Autophagy via the AMPK/mTOR Signaling., PMID:40526157

Optimizing enfortumab vedotin plus pembrolizumab therapy., PMID:40526099

MiR-106b-5p, MiR-200c-3p, and MiR-146a-5p expression as putative biomarkers for disease state in primary immune thrombocytopenia., PMID:40526093

Case Report WIN-MTB-2023001 WIN International Molecular Tumor Board A 62-year-old male with metastatic colorectal cancer with 5 prior lines of treatment., PMID:40526090

Randomized phase II clinical trial of cisplatin/carboplatin and etoposide (PE) alone or in combination with nivolumab as frontline therapy for extensive-stage small cell lung cancer (ES-SCLC): ECOG-ACRIN EA5161., PMID:40526078

Detection of Alzheimer's Disease Neuropathology in Chronic Kidney Disease: Current State and Future Directions., PMID:40525987

Cranial Myorhythmia as a Novel Clinical Manifestation in Contactin-Associated Protein-like 2 (CASPR2) Antibody Associated Encephalitis., PMID:40525980

[Paraneoplastic limbic encephalitis - an important differential diagnosis in cases of unclear encephalopathy]., PMID:40525932

BKPyV-specific T-cell Exhaustion in Kidney Transplant Recipients: Targeting Inhibitory Receptors Improves Their Functionality., PMID:40525862

Corneal Perforation Associated With Tralokinumab., PMID:40525846

Plasmonic ELISA for Biomarker Detection: A Review of Mechanisms, Functionalization Strategies, and Emerging Modalities., PMID:40525845

Misdiagnosis of ANCA-Associated Vasculitis in Patients With Cocaine/Levamisole-Associated Autoimmune Syndrome and Cocaine-Induced Midline Destructive Lesions: A Case Series., PMID:40525737

Immunogenicity of the Comirnaty Omicron XBB.1.5 booster COVID-19 mRNA vaccine in patients with cirrhosis., PMID:40525725

Expression of Heart Development Protein With EGF-Like Domains 1 (HEG1) Decorated With Low-Sulfated Keratan Sulfate in Human Malignant Pleural Mesothelioma., PMID:40525709

Comparison of Intrapatient Variability of IR-Tacrolimus Versus LCP-Tacrolimus in a Cohort of Lung Transplant Recipients., PMID:40525559

Long-Term Humoral Immune Response After West Nile Virus Convalescence in Horses in a Geographic Area of Multiple Orthoflavivirus Co-Circulation., PMID:40525557

Simultaneous Determination of Atezolizumab and Bevacizumab by LC-MS/MS in Rat Plasma and Its Application to a Pharmacokinetic Study., PMID:40525526

A Prognostic Index for Advanced Biliary Tract Cancer Treated With Cisplatin, Gemcitabine and Durvalumab: The MAGIC-D Index., PMID:40525496

Sjögren's disease with mixed cryoglobulinemia presenting as a hypertensive emergency with thrombotic microangiopathy: a diagnostic puzzle., PMID:40525383

Lupus anticoagulant testing in Belgian laboratories: a comparison with the 2020 International Society on Thrombosis and Haemostasis Scientific and Standardization Committee (ISTH-SSC) guidelines., PMID:40525382

Inflammatory signatures and immunomodulation in neonates: a pilot study., PMID:40525368

The effectiveness of the De Ritis ratio in diagnosis and follow-up of Celiac disease: A Retrospective Study., PMID:40525362

[Recent progress in the regulation of cellular immunity to erythrocyte homologous immunity]., PMID:40525345

[Prokaryotic expression of mouse LRP16, preparation and identification of rabbit anti-mouse LRP16 polyclonal antibody]., PMID:40525343

[Research on the inhibitory effects of evodiamine on activated T cell proliferation]., PMID:40525340

A Permeabilization Workflow To Enable Specific Multiplexed Profiling Using SERS Nanoparticles., PMID:40525305

In-vivo-targeted gene delivery using adenovirus-antibody site-specific covalent conjugates., PMID:40525123

Evaluation of Methods Employed in Establishing Preclinical Similarity of Adalimumab Biosimilars., PMID:40525119

Characteristics of Older Individuals with Asthma Being Treated with Biologics., PMID:40525103

Rapid Progression of Dermatomyositis in an Elderly Patient With Oropharyngeal and Pulmonary Involvement: A Case Report., PMID:40525043

Pattern Distribution and Utility of Reporting Anticellular Antibody Over Antinuclear Antibody: An Initial Report From the Immunofluorescence Laboratory of North Bengal Medical College and Hospital, West Bengal., PMID:40524999

Sjögren's Syndrome Associated With Erythema Dyschromicum Perstans: A Rare Dermatological Manifestation., PMID:40524988

Emerging roles of protein arginine methyltransferase in multiple myeloma., PMID:40524859

Real-world uptake of nirsevimab, RSV maternal vaccine, and RSV vaccines for older adults: a systematic review and meta-analysis., PMID:40524797

Datasheet

Document Download

Research Grade Varokibart.pdf

 

$ 372
Product specifications
100 μg 372 1 mg 1486

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Research Grade Varokibart [DHC13604]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only